Rx (Prescription Medicine)
USD $ 120.00
Vegfxta 400mg 注射液是一种靶向疗法，用于治疗某些类型的癌症。其活性成分通过抑制血管内皮生长因子（VEGF）发挥作用，而VEGF是一种在新血管形成中起关键作用的蛋白质。通过阻断VEGF，Vegfxta有助于使肿瘤缺乏生长和扩散所需的血液供应。该药物通常作为综合癌症治疗方案的一部分，常与化疗联合使用。剂量和治疗时长取决于患者的具体病情、对疗法的反应以及其他医学因素。常见的不良反应可能包括高血压、疲劳、腹泻和伤口愈合受损。患者应告知其医疗提供者任何既往疾病，尤其是心脏问题或出血性疾病。Vegfxta 400mg 注射液应储存在室温，避光保存，并置于儿童不易触及的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength |
其他品牌的 Bevacizumab 400 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
